KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Other Non-Current Assets (2016 - 2026)

AbbVie has reported Other Non-Current Assets over the past 14 years, most recently at $10.7 billion for Q4 2025.

  • Quarterly Other Non-Current Assets rose 17.27% to $10.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.7 billion through Dec 2025, up 17.27% year-over-year, with the annual reading at $10.7 billion for FY2025, 17.27% up from the prior year.
  • Other Non-Current Assets was $10.7 billion for Q4 2025 at AbbVie, up from $9.6 billion in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $10.7 billion in Q4 2025 and troughed at $4.7 billion in Q3 2021.
  • The 5-year median for Other Non-Current Assets is $6.6 billion (2023), against an average of $7.1 billion.
  • The largest YoY upside for Other Non-Current Assets was 81.65% in 2021 against a maximum downside of 0.68% in 2021.
  • A 5-year view of Other Non-Current Assets shows it stood at $4.9 billion in 2021, then grew by 14.07% to $5.6 billion in 2022, then surged by 52.81% to $8.5 billion in 2023, then grew by 7.39% to $9.1 billion in 2024, then increased by 17.27% to $10.7 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Other Non-Current Assets are $10.7 billion (Q4 2025), $9.6 billion (Q3 2025), and $9.7 billion (Q2 2025).